Mabtas 100 – Rituximab Injection for Cancer & Autoimmune Disorders

Mabtas 100 contains Rituximab, a monoclonal antibody used in the treatment of non-Hodgkin’s lymphoma (NHL), chronic lymphocytic leukemia (CLL), and autoimmune diseases like rheumatoid arthritis. It works by targeting and destroying cancerous or overactive immune cells. Administered via intravenous infusion under medical supervision.